Publications by authors named "Susann Varano"

Claim this Profile
P
Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults?
Jennifer King, Nancy Tuders, Susann Varano, Janet Owens-Grillo

Ther Adv Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
Jeffrey Frankel, David Staskin, Susann Varano, Diane K Newman, Steven G Gregg

J Comp Eff Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study.
David Staskin, Jeffrey Frankel, Steven G Gregg, Susann Varano, Janet Owens-Grillo

J Comp Eff Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial.
Diane K Newman, Elizabeth Thomas, Heather Greene, Cornelia Haag-Molkenteller, Susann Varano

Urogynecology (Phila)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial.
David Staskin, Jeffrey Frankel, Susann Varano, Michael Kennelly, Diane K Newman

Int J Clin Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder.
Jeffrey Frankel, David Staskin, Susann Varano, Michael J Kennelly, Rachael A Jankowich

Ther Clin Risk Manag· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR.
Jeffrey Frankel, David Staskin, Susann Varano, Michael Kennelly, Diane K Newman

Adv Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibegron improves quality-of-life measures in patients with overactive bladder: Patient-reported outcomes from the EMPOWUR study.
Jeffrey Frankel, Susann Varano, David Staskin, Denise Shortino, Rachael Jankowich

Int J Clin Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR).
David Staskin, Jeffrey Frankel, Susann Varano, Denise Shortino, Rachael Jankowich

J Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
David Staskin, Jeffrey Frankel, Susann Varano, Denise Shortino, Rachael Jankowich

J Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Daily Vibegron for Treatment of Overactive Bladder in Patients Aged ≥65 and ≥75 Years: Subpopulation Analysis from the EMPOWUR Randomized, International, Phase III Study.
Susann Varano, David Staskin, Jeffrey Frankel, Denise Shortino, Rachael Jankowich

Drugs Aging· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.
Roger R Dmochowski, Sydney Thai, Kristy Iglay, Ekene Enemchukwu, Silvia Tee, Susann Varano

Neurourol Urodyn· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR.
David Staskin, Jeffrey Frankel, Susann Varano, Denise Shortino, Rachael Jankowich

J Urol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
David Staskin, Jeffrey Frankel, Susann Varano, Denise Shortino, Rachael Jankowich

J Urol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis